Brief: Poxel Finalized Recruitment In Phase II Study Of PXL065
Sept 21 (Reuters) - Poxel SA POXEL.PA :
* FINALIZED THE RECRUITMENT OF PATIENTS WITH NON-CIRRHOTIC
NASH
CONFIRMED BY BIOPSY IN THE PHASE II STUDY OF PXL065 (DESTINY-1)
* FIRST RESULTS OF THE PHASE II STUDY OF 123 PATIENTS WITH
NON-CIRRHOTIC NASH CONFIRMED BY BIOPSY ARE EXPECTED IN Q3 OF
2022
Source text for Eikon: ID:nBwbKDRqPa
Further company coverage: POXEL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Poxel SA
See all newsFrance's Poxel Q3 revenue rises on higher TWYMEEG royalties
France's Poxel Q2 revenue rises on higher TWYMEEG royalties
France's Poxel Q1 revenue rises 20% on TWYMEEG sales
Brief: Poxel Announces That A Combined General Meeting Will Be Held On December 11, 2025 And The Availability Of The Preparatory Documents
Brief: Poxel Says Cash Runway Estimated Between Mid To End Q2 2025